Rep. Pete Sessions

Maddy summaryThis bill creates a presumption that minerals from the Democratic Republic of Congo (DRC) containing cobalt and lithium, mined with child or forced labor, cannot be imported into the United States. It requires the U.S. government to develop an enforcement strategy to identify and block such imports, including monitoring supply chains and working with international partners. The bill mandates diplomatic efforts to address child and forced labor in the DRC's mining sector and establishes sanctions against foreign entities that facilitate or engage in such labor practices. The focus is on minerals critical for electric vehicles and electronics, which are heavily sourced from the DRC and processed in China, with specific attention to Chinese mining companies like China Molybdenum that dominate the DRC's cobalt sector.

Maddy summaryThis bill prohibits Medicare from paying for certain custom-fitted or custom-fabricated orthotic and prosthetic devices delivered via "drop shipment" (direct shipping without in-person training from a qualified provider). It directly affects Medicare beneficiaries who need these devices, ensuring they receive necessary in-person fitting and training. The bill also expands which healthcare professionals (including physical therapists, occupational therapists, orthotists, and prosthetists) can prescribe these devices and updates definitions to clarify terms like "orthoses" and "prostheses." Final regulations implementing these changes must be issued within one year of the bill's enactment.

Maddy summaryThe ARC Act of 2023 establishes a national program to address peripheral artery disease (PAD), which disproportionately affects minority populations and leads to avoidable amputations. The bill requires Medicare and Medicaid to cover PAD screening tests (such as ankle-brachial index testing) for at-risk beneficiaries without cost-sharing, including people 65+ or those with diabetes, smoking history, or other risk factors. It authorizes $6 million annually for a CDC-led education program to inform healthcare providers and the public about PAD prevention and treatment. The bill also creates quality measures to encourage alternative treatments to amputation and establishes a pilot program to test amputation prevention services at healthcare facilities. These provisions aim to reduce amputation rates and improve outcomes for millions of Americans with PAD.

Maddy summaryHR 3674 increases Medicare payments for specific physician services that rely heavily on equipment and supplies (defined as services where 65%+ of costs are for equipment/supplies). It raises payment rates by 10% in 2024 and 15% in 2025 for these services in non-hospital settings like doctor's offices. The bill funds these increases through federal appropriations to the Medicare Trust Fund. It directly affects physicians and clinics providing those defined services, aiming to stabilize reimbursement for providers of high-cost equipment-dependent care.

Maddy summaryHR 3129, the Health Care Fairness for All Act, repeals the individual and employer health insurance mandates established under the Affordable Care Act. The bill provides states with increased flexibility to regulate health insurance outside of health insurance exchanges while maintaining certain consumer protections like coverage for pre-existing conditions and dependent coverage through age 26. It introduces a new health insurance tax credit to help individuals afford coverage and changes Health Savings Accounts (HSAs) to be non-deductible. The bill also includes Medicare reforms such as promoting site-neutral payments and extending acute hospital care at home programs.

Maddy summaryThe Border Reinforcement Act of 2023 requires the immediate resumption of border wall construction along the US-Mexico border using previously allocated funds, with annual goals to complete 200 miles of wall until operational control is achieved. It mandates a comprehensive 5-year technology investment plan for border security systems, including surveillance and detection technology, and sets staffing requirements for U.S. Border Patrol, including a target of 22,000 full-time equivalent agents by 2025. The bill also requires U.S. Customs and Border Protection to publish monthly operational statistics on border encounters, drug seizures, and other border security metrics. Additionally, it includes provisions for DNA collection at land borders, eradication of certain vegetation impeding border security, and a report on Mexican cartels as potential foreign terrorist organizations.

Maddy summaryHR 2639 requires Medicare to only pay for nerve conduction studies and needle electromyography tests (electrodiagnostic services) provided at "qualified facilities" starting 3-4 years after enactment. A qualified facility must be accredited by an organization approved by the Secretary of Health and Human Services and meet specific standards, including having a quality program, using approved equipment, ensuring staff have adequate training, and requiring on-site interpretation of results during the procedure. The bill also mandates the Secretary to establish an advisory committee to recommend standards for accreditation and quality improvements in these services. This affects facilities providing electrodiagnostic testing and aims to standardize care through accreditation requirements.

Maddy summaryHR 2474, the "Strengthening Medicare for Patients and Providers Act," changes how Medicare pays physicians for services. It replaces the previous two-part payment system (used through 2025) with a single annual payment rate update starting in 2024. This update will be based on the Medicare Economic Index (MEI), which tracks costs for medical providers. The change directly affects Medicare-certified doctors and clinics who receive payments under the physician fee schedule.

Maddy summaryThis bill would require Medicare to cover FDA-approved blood tests that screen for multiple cancers simultaneously (like breast, lung, or colorectal cancer) for beneficiaries. It directly affects Medicare recipients aged 65+ who could access these new screenings once per year, without prior authorization. The key provision adds "multi-cancer early detection screening tests" to Medicare's covered services under Part B, defining them as blood tests analyzing cell-free DNA, while maintaining existing coverage for standard screenings like mammograms. The bill does not change current coverage for individual cancer screenings but ensures Medicare keeps pace with new medical technology.

Maddy summaryThis bill requires Medicare, Medicaid, and CHIP to cover advanced genetic cancer testing (like DNA/RNA sequencing and their interpretation) for patients diagnosed with cancer. It defines covered tests as next-generation sequencing performed by clinical labs and limits coverage to once per diagnosis, recurrence, or treatment monitoring. Medicare will pay 80% of the test cost (or 100% if billed under assignment), while Medicaid and CHIP must include these tests in mandatory coverage starting January 1, 2025. The bill directly affects cancer patients enrolled in these federal health programs by ensuring access to specific genetic testing without excessive out-of-pocket costs.